Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer

Summary

RATIONALE: Analyzing genes for changes before and after chemotherapy may help doctors predict a patient's response to treatment and help plan the most effective treatment. PURPOSE: This clinical trial is studying how well genetic testing works in predicting response to paclitaxel in women who have unresected breast cancer.

Timeline

Start

2001-04

Primary completion

2012-12

Completion

2012-12

Outcome

Outcome not reported

Stopped: “Investigator left institution”

Drugs

Indications